COMMUNIQUÉS West-GlobeNewswire

Cesca Therapeutics to Announce Financial Results for the Second Quarter Ended June 30, 2018 and Host Conference Call on August 13
06/08/2018
RANCHO CORDOVA, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based [...]
Concierge Care Advisors Promotes Social Connections for Seniors with Seattle Mariners Ticket Giveaway
06/08/2018
CCA contest awards free tickets for resident seniors at local care facilities for an upcoming baseball game SEATTLE, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Concierge Care Advisors , a pioneering senior care and housing [...]
Transactions under Novozymes’ stock buyback program
06/08/2018
Please read the full announcement in the attached PDF Attachment 2018_46_Stock_Buybackprogram_EN
Catalyst Pharmaceuticals Expands Commercial Leadership Team
06/08/2018
Augments Medical Affairs Team with 3 Additional Medical Science Liaisons CORAL GABLES, Fla., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company [...]
Krystal Biotech Reports Second Quarter 2018 Financial Results and Provides Corporate Update
06/08/2018
First two patients enrolled in Phase 1/2 clinical study of KB103, a first-in-class topical gene therapy for the treatment of dystrophic epidermolysis bullosa. PITTSBURGH, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Krystal [...]
Inovio Partners with AIDS Malignancy Consortium to Advance Inovio’s HPV Therapy for High-Grade Anal Dysplasia in HIV-positive Patients
06/08/2018
VGX-3100 previously demonstrated Phase 2b efficacy in regressing HPV-related cervical precancer PLYMOUTH MEETING, Pa., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that it [...]
Samumed Closes on $438 Million in Equity Financing
06/08/2018
SAN DIEGO, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it has closed its A-6 Round of equity issuance with $438 million, bringing its total equity raised to date to more than $650 million. The [...]
Delcath Announces Commencement of Rights Offering Subscription Period
06/08/2018
NEW YORK, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces the subscription period for [...]
Rexahn Reports Second Quarter 2018 Financial Results
06/08/2018
ROCKVILLE, Md., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, [...]
Fortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement with the University of Pennsylvania to Advance AAV Gene Therapy Technology
06/08/2018
Agreement drives further testing of Aevitas’ AAV gene therapy technology in animal models of complement-mediated diseases NEW YORK, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech (NASDAQ:FBIO) (“Fortress”), a [...]
BioSig Technologies Added to LD Micro Index
06/08/2018
Santa Monica, CA, Aug. 06, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( BSGM ), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology [...]
TG Therapeutics, Inc. to Host Conference Call on Second Quarter 2018 Financial Results and Business Update
06/08/2018
Investor Conference Call to be tomorrow, Tuesday, August 7, 2018 at 4:30pm ET NEW YORK, Aug. 06, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held [...]
Indication for Use of SAVI SCOUT® Wire-Free Radar Breast Localization System Expands to Include Localization of Soft Tissue
06/08/2018
The SCOUT reflector can now be used to mark soft tissue sites including lymph nodes ALISO VIEJO, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Cianna Medical, Inc., the world leader in wire-free breast localization, [...]
VIVUS Appoints Kenneth Suh as President
06/08/2018
CAMPBELL, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, today announced the appointment of Ken Suh to the position of President. Previously, Mr. Suh [...]
Otonomy Announces OTIPRIO® Co-Promotion Agreement with Mission Pharmacal for Acute Otitis Externa Indication
06/08/2018
SAN DIEGO, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced the signing of a co-promotion [...]
AMAG Pharmaceuticals Appoints Brian Robinson, M.D. as Senior Vice President of Medical Affairs
06/08/2018
WALTHAM, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Brian Robinson, M.D. as senior vice president, medical affairs, reporting into Julie Krop, M. [...]
Kiniksa Reports Second Quarter 2018 Financial Results and Pipeline Progress
06/08/2018
– Rilonacept advancing toward pivotal Phase 3 clinical trial in 2H 2018 following recent End-of-Phase 2 communication with FDA – – KPL-716 single-dose Phase 1a/1b Last Subject Last Visit achieved; clinical trial data [...]
Ovid Therapeutics Announces Positive Topline Data from Phase 2 STARS Trial of OV101 for the Treatment of Angelman Syndrome
06/08/2018
-- OV101 achieved primary endpoint of safety and tolerability -- -- Robust and statistically significant improvement (p=0.0006) in the first prespecified efficacy endpoint (CGI-I) observed at 12 weeks of treatment in [...]
miRagen Therapeutics and The Leukemia & Lymphoma Society® Enter Into an Agreement to Facilitate the Development of Cobomarsen in Cutaneous T-Cell Lymphoma
06/08/2018
BOULDER, Colo. and RYE BROOK, N.Y., Aug. 06, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted [...]

Pages